From the Journals

Omicron subvariant 1.5 times more contagious than Omicron


 

The Omicron subvariant, known as BA.2, spreads about 1.5 times faster than the original Omicron strain, known as BA.1, according to CNBC.

The Statens Serum Institut, which monitors infectious diseases in Denmark, said that BA.2 is more contagious, but it doesn’t appear to increase hospitalizations or reduce how well the vaccine works.

BA.2 overtook BA.1 as the primary variant in Denmark within a few weeks, Troels Lillebaek, director of the institute, told CNBC. The subvariant has five unique mutations on a key part of the spike protein, which is what the coronavirus uses to invade human cells. This often means a higher rate of spreading.

The Omicron subvariant has been detected in at least 29 states in the United States and 56 countries, according to the latest update from Outbreak.info. The United States has detected 188 infections, with the worldwide total nearing 25,000.

Denmark has reported the highest number of cases, followed by the United Kingdom and India. Both Denmark and India have reported that BA.2 now accounts for about half of new COVID-19 cases in those countries.

On Jan. 28, the U.K. Health Security Agency said BA.2 has a “substantial” growth advantage over the original Omicron strain. The subvariant has spread faster in all regions of England where there were enough cases to conduct an analysis, the agency said in a report.

A preliminary evaluation found that BA.2 doesn’t appear to change how well the vaccine works compared to the original Omicron strain, the agency said. A booster dose was 70% effective at preventing symptomatic illness for BA.2, compared with 63% for the original Omicron strain.

The Centers for Disease Control and Prevention also said on Jan. 28 that, although the subvariant has become more common in some countries, it is currently at a low level in the United States and doesn’t appear to be more serious.

“Currently there is no evidence that the BA.2 lineage is more severe than the BA.1 lineage,” Kristen Nordlund, a CDC spokesperson, told CNBC.

The World Health Organization hasn’t labeled BA.2 a “variant of concern” so far but will continue to monitor it. WHO officials have said that new variants will arise as Omicron spreads across the world.

“The next variant of concern will be more fit, and what we mean by that is it will be more transmissible because it will have to overtake what is currently circulating,” Maria Van Kerkhove, the WHO’s COVID-19 technical lead, said during a livestream on Jan. 25.

“The big question is whether or not future variants will be more or less severe,” she said.

A version of this article first appeared on WebMD.com.

Recommended Reading

Watch, but don’t worry yet, about new Omicron subvariant
MDedge Hematology and Oncology
Omicron survives longer on plastic, skin than other COVID variants
MDedge Hematology and Oncology
35% of employers to proceed with vaccine mandate, poll shows
MDedge Hematology and Oncology
We’re dying to tell you about fatigability
MDedge Hematology and Oncology
Another winter for our discontent
MDedge Hematology and Oncology
Get free masks at grocery stores and pharmacies starting Jan. 28
MDedge Hematology and Oncology
Hong Kong, U.S., Israeli data illuminate COVID vaccine myocarditis
MDedge Hematology and Oncology
Immunocompromised patients should receive fourth COVID shot: CDC
MDedge Hematology and Oncology
Long COVID is real, and many real questions remain
MDedge Hematology and Oncology
FDA grants full approval to Moderna COVID-19 vaccine
MDedge Hematology and Oncology